Classifying the intensity of pediatric cancer treatment protocols: the intensity of treatment rating scale 2.0 (ITR-2).

Classifying the intensity of pediatric cancer treatment protocols: the intensity of treatment rating scale 2.0 (ITR-2). Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Classifying the intensity of pediatric cancer treatment protocols: the intensity of treatment rating scale 2.0 (ITR-2). Abstract Text:

Branlyn E Werba,Wendy Hobbie,Anne E Kazak,Richard F Ittenbach,Anne F Reilly,Anna T Meadows,

BACKGROUND: To develop and validate a method of classifying the intensity of pediatric oncology treatments using four operationally defined categories of treatment intensity. PROCEDURE: An earlier version of a rating scale, the intensity of treatment rating (ITR), was revised and validated in two phases. In the Scale Construction phase, three criterion raters revised the ITR items based on consensus and item agreement data from pediatric oncologist raters (N = 15). In the Scale Validation phase, the new ITR-2 items were validated using a second set of pediatric oncologists external to our institution (N = 12). In addition, a third group of raters (N = 16), was employed to assess inter-rater reliabilities for 12 patients at varying levels of treatment intensities. RESULTS: Agreement between criterion ratings and the median of external raters for all 34 items on the ITR-2 was very high (r = 0.95, range 0.71-0.91). When the ITR-2 was used to rate 12 patient examples, the inter-rater agreement among pediatric oncologists was also very high (median agreement between criterion-rater pairs: r = 0.87; overall relatedness among 16 raters: r(ICC) = 0.83). CONCLUSIONS: The revised ITR Scale 2.0 (ITR-2) is a valid and reliable scale for classifying the intensity of pediatric oncology treatments.

Classifying the intensity of pediatric cancer treatment protocols: the intensity of treatment rating scale 2.0 (ITR-2). Publishing Authors By Initials

BE Werba,W Hobbie,AE Kazak,RF Ittenbach,AF Reilly,AT Meadows,

For similar investigative techniques: epidemiologic methods: statistics as topic: probability: risk: risk factors research abstracts see: investigative techniques: epidemiologic methods: statistics as topic: probability: risk: risk factors research

PUBMED ID PMID:

MEDLINE DATE:

Classifying the intensity of pediatric cancer treatment protocols: the intensity of treatment rating scale 2.0 (ITR-2). Journal Published:

PUBLICATION TYPE: Validation Studies

Journal: Pediatric blood & cancer

VOLUME: 48

Page Numbers: 673-7

Journal Abbreviation:

ISSN: 1545-5009

DAY: 15

MONTH: Jun

YEAR: 2007

Classifying the intensity of pediatric cancer treatment protocols: the intensity of treatment rating scale 2.0 (ITR-2). Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101186624

Classifying the intensity of pediatric cancer treatment protocols: the intensity of treatment rating scale 2.0 (ITR-2). Keywords Mesh Terms:

KEYWORDS: Risk Factors

MESH TERMS: therapy

Chemical & Substance for Abstract: Classifying the intensity of pediatric cancer treatment protocols: the intensity of treatment rating scale 2.0 (ITR-2). Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Classifying the intensity of pediatric cancer treatment protocols: the intensity of treatment rating scale 2.0 (ITR-2).

AFFILIATION: Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104-4399, USA.

Country: United States

AGENCY: United States NCI

GRANT: CA106928

ACRONYM: CA

MEDLINETA: Pediatr Blood Cancer

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Classifying the intensity of pediatric cancer treatment protocols: the intensity of treatment rating scale 20 ITR-2 Related Publications

• A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy.
• Bronchospasm during excretory urography: lack of specificity for the methylglucamine cation.
• CT of sarcomatous degeneration in neurofibromatosis.
• Case 1: Psychological feeding disorder? (Case Presentation).
• Case 1: Psychological feeding disorder? (Discussion and Diagnosis).
• Case report: a patient with anti-'N'.
• Chronic alcohol consumption perturbs the balance between thymus-derived and bone marrow-derived natural killer cells in the spleen.
• Classifying the intensity of pediatric cancer treatment protocols: the intensity of treatment rating scale 2.0 (ITR-2).
• EXPERIMENTAL CLINIC FOR PREVENTING CHRONIC BRONCHITIS.
• Elder mistreatment in the nursing home: a systematic review.
• Evidence-based assessment, intervention and psychosocial care in pediatric oncology: a blueprint for comprehensive services across treatment.
• Factors involved in modulation of NK cell activity by ethanol consumption.
• HEALTH EXAMINATIONS OF SENIOR STAFF IN INDUSTRY.
• Implant technology and usability.
• Increased class 3 semaphorin expression modulates the invasive and adhesive properties of prostate cancer cells.
• Neurology; medical.
• Precorneal residence time of artificial tears measured in dry eye subjects.
• Retinoblastoma: approaching international standards for recommending chemotherapy (Commentary on Chantada et al., page 692).
• Rhabdomyosarcoma presenting as a calf pyomyositis.
• SCINTILLATION SCANNING OF BRAIN TUMORS.
• Selective amino acid restriction differentially affects the motility and directionality of DU145 and PC3 prostate cancer cells.
• Skeletal metastases from cerebellar medulloblastoma.
• Specific amino acid dependency regulates the cellular behavior of melanoma.
• Sperm banking for adolescent and young adult cancer patients: sperm quality, patient, and parent perspectives.
• Staphylococcal enterotoxins G and I, a cause of severe but reversible neonatal enteropathy.
• Studies on the mechanism of alimentary lysozyme production. II.
• Subtotal gastrectomy or vagotomy for peptic ulcerations; early results and postoperative symptoms.
• Tamanu (Calophyllum inophyllum) - the African, Asian, Polynesian and Pacific Panacea.
• The ferguson medial approach for open reduction of developmental dysplasia of the hip. A clinical and radiological review of 49 hips.
• Transferrin reverses the anti-invasive activity of human prostate cancer cells that overexpress sema3E.